Genesis partnered with the National Institute for Communicable Diseases (NICD) on a landmark household cohort study in South Africa, central to the country’s efforts to monitor vaccine-preventable illnesses and shape national immunisation policy. From 2022 to 2025, Genesis led the SARS-CoV-2 and Multi-pathogen Serosurveillance (SAMS) longitudinal study, bringing deep expertise in data collection, management, and quality assurance to a complex, multi-year research programme.

Genesis is supporting UNICEF India to analyse how gender differentials in the Indian states of Maharashtra and Bihar are impacting the effectiveness of immunisation efforts. The initiative is part of our long-term agreement to provide behavioural sciences services to UNICEF.

Genesis Analytics partnered with the United Nations Population Fund to develop the regional Sexual and Reproductive Health and RightscTechnical Assistance (TA) Hub for the 2gether 4 SRHR programme.

Genesis has been contracted by the Gates Foundation to synthesise and contextualise evidence to guide countries in managing and implementing comprehensive HIV prevention responses for adolescent girls and young women (AGYW).

Genesis has been contracted by the International Planned Parenthood Federation (IPPF) to conduct the second round of client exit interviews (CEIs) for family planning clients in 17 countries in Africa and Asia through the WISH2 project.